Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |